Vitamin D supplementation and neurofilament light chain in multiple sclerosis.

Trygve HolmøyEgil RøsjøHenrik ZetterbergKaj BlennowJonas Christoffer LindstrømLinn Hofsøy SteffensenMargitta T Kampman

Published in: Acta neurologica Scandinavica (2018)

With a possible exception for patients not treated with disease-modifying drugs, weekly supplementation with 20 000 IU vitamin D3 did not affect NFL levels in these RRMS patients.

Keyphrases

end stage renal disease
multiple sclerosis
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes
drug induced